Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Aryl substituted 3-ethoxy phenyl trifluoromethane sulfonamides for the treatment of non-insulin dependent diabetes mellitus (NIDDM)

Aryl substituted 3-ethoxy phenyl trifluoromethane sulfonamides for the treatment of non-insulin dependent diabetes mellitus (NIDDM)

US Patent 6930131 · Granted Aug 16, 2005

Estimated economic value: $152,469,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucose uptake inhibitors2024
Treatment of inflammatory conditions and autoimmune diseases with glucose uptake2021
Glucose uptake inhibitors2021
Glucose uptake inhibitors2019
Rapamycin conjugates and antibodies2011
Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands2010
Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands2010
Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibi2010
Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azo2010
3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof2010
3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof2010
Aryl sulfamide derivatives and methods of their use2009